{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:14:15Z","timestamp":1786115655469,"version":"build-2736575974"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Tuberc."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Latent tuberculosis infection (LTBI) represents a major global reservoir for active disease, characterized by persistent, metabolically inactive bacilli that are difficult to eradicate. Novel therapeutic approaches targeting bacterial persistence and host immune responses are needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A rabbit model of latent-like mycobacterial infection was established using aerosolized\n                      <jats:italic>Mycobacterium aurum<\/jats:italic>\n                      . The rabbits were treated with isoniazid and rifapentine (HR), ethanolic extract of\n                      <jats:italic>Allium cepa<\/jats:italic>\n                      (EAC), and combination therapy. Treatment efficacy was evaluated using colony-forming unit (CFU) counts and haematological parameters (WBC, neutrophils, lymphocytes).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The CFU counts increased significantly during the induction phase, confirming successful establishment of the latent-like mycobacterial infection model, while stabilization of bacterial load over time suggested immune-mediated containment. During the treatment phase, significant reductions in CFU counts were observed in all treated groups compared with untreated controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.0001), with the greatest reduction seen in combination therapy groups (HR\u2009+\u2009\n                      <jats:italic>Allium cepa<\/jats:italic>\n                      extract), indicating an improved efficacy relative to monotherapy. Haematological analysis revealed significant increases in WBC, neutrophils, and lymphocytes during infection, reflecting immune activation. Treatment resulted in normalization of WBC counts, reduction in neutrophilia, and stabilization of lymphocyte levels, indicating attenuation of inflammation and restoration of immune balance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Allium cepa<\/jats:italic>\n                      demonstrated antimycobacterial and immunomodulatory effects in a rabbit model of latent-like mycobacterial infection and may have potential as an adjunctive therapeutic strategy in LTBI management.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/ftubr.2026.1874315","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:24:34Z","timestamp":1785990274000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Adjunctive antimycobacterial and immunomodulatory effects of Allium cepa (pink variety) in a rabbit model of latent-like mycobacterial infection"],"prefix":"10.3389","volume":"4","author":[{"given":"Theophilus Kwesi","family":"Ninkyi","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology (KNUST)","place":["Kumasi, Ghana"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ogyam","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology (KNUST)","place":["Kumasi, Ghana"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin Atta","family":"Agyapong","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology (KNUST)","place":["Kumasi, Ghana"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Amaning Danquah","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology (KNUST)","place":["Kumasi, Ghana"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/J.IJID.2022.05.029","article-title":"Prevalence trends of latent tuberculosis infection at the global, regional, and country levels from 1990 to 2019","volume":"122","author":"Ding","year":"2022","journal-title":"Int J Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/TROPICALMED7030048","article-title":"The biological and clinical aspects of a latent tuberculosis infection","volume":"7","author":"Khabibullina","year":"2022","journal-title":"Trop Med Infect Dis"},{"key":"B3","year":""},{"key":"B4","doi-asserted-by":"publisher","first-page":"745592","DOI":"10.3389\/FMICB.2021.745592\/FULL","article-title":"Differential diagnosis of latent tuberculosis infection and active tuberculosis: a key to a successful tuberculosis control strategy","volume":"12","author":"Gong","year":"2021","journal-title":"Front Microbiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/S43556-022-00106-Y","article-title":"The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development","volume":"3","author":"Yan","year":"2022","journal-title":"Mol Biomed"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.ijid.2019.02.035","article-title":"Latent TB infection (LTBI) \u2013 Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground","volume":"80","author":"Rao","year":"2019","journal-title":"Int J Infect Dis"},{"key":"B7","year":""},{"key":"B8","doi-asserted-by":"publisher","first-page":"16240","DOI":"10.1038\/S41598-023-43310-8","article-title":"Efficacy of anti-tuberculosis drugs for the treatment of latent tuberculosis infection: a systematic review and network meta-analysis","volume":"13","author":"Yoopetch","year":"2023","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/J.IJID.2021.02.094","article-title":"Implementing tuberculosis preventive treatment in high-prevalence settings","volume":"113","author":"Fox","year":"2021","journal-title":"Int J Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/JAMA.2022.24362","article-title":"Management of latent tuberculosis infection","volume":"329","author":"Kim","year":"2023","journal-title":"J Am Med Assoc"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3390\/V16071163","article-title":"HIV persistence, latency, and cure approaches: where are we now?","volume":"16","author":"Chou","year":"2024","journal-title":"Viruses"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4662","DOI":"10.3390\/MOLECULES26154662","article-title":"Inhibition of bacterial efflux pumps by crude extracts and essential oil from myristica fragrans houtt. (nutmeg) seeds against methicillin-resistant staphylococcus aureus","volume":"26","author":"Oo","year":"2021","journal-title":"Molecules"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.3390\/MOLECULES30112393","article-title":"Natural products as antimicrobial agents: from extraction to therapeutic applications","volume":"30","author":"Rivi\u00e8re","year":"2025","journal-title":"Molecules"},{"key":"B14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3897\/pharmacia.70.e99666","article-title":"Update review: etnopharmacological, bioactivity and phytochemical of Allium cepa L","volume":"70","author":"Prima","year":"2023","journal-title":"Pharmacia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"112498","DOI":"10.1016\/J.BIOPHA.2021.112498","article-title":"Onion (Allium cepa L.) peels: a review on bioactive compounds and biomedical activities","volume":"146","author":"Kumar","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"B16","doi-asserted-by":"publisher","first-page":"12591","DOI":"10.3390\/MOLECULES190812591","article-title":"Allicin: chemistry and biological properties","volume":"19","author":"Borlinghaus","year":"2014","journal-title":"Molecules"},{"key":"B17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/J.IJANTIMICAG.2011.02.014","article-title":"Recent advances in understanding the antibacterial properties of flavonoids","volume":"38","author":"Cushnie","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3390\/PLANTS13131727\/S1","article-title":"Diversity of the morphometric and biochemical traits of Allium cepa L. varieties","volume":"13","author":"Arena","year":"2024","journal-title":"Plants"},{"key":"B19","first-page":"1","article-title":"Antimicobial potentials of fresh Allium cepa against gram positive and gram negative bacteria and fungi","volume":"45","author":"Bakht","year":"2013","journal-title":"Pak J Bot"},{"key":"B20","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3390\/ANTIBIOTICS10080902","article-title":"Investigating Ghanaian Allium species for anti-infective and resistance-reversal natural product leads to mitigate multidrug-resistance in Tuberculosis","volume":"10","author":"Danquah","year":"2021","journal-title":"Antibiotics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.tube.2007.10.006","article-title":"The aerosol rabbit model of TB latency, reactivation and immune reconstitution inflammatory syndrome","volume":"88","author":"Manabe","year":"2008","journal-title":"Tuberculosis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/978-3-030-56905-1_19","article-title":"The rabbit model for assessing host-directed therapies for tuberculosis","author":"Subbian","year":"2020","journal-title":"Adv Host Dir Ther Against Tuberc"},{"key":"B23","doi-asserted-by":"publisher","first-page":"456","DOI":"10.4103\/IJMR.IJMR_554_18","article-title":"Animal models of tuberculosis: lesson learnt","volume":"147","author":"Singh","year":"2018","journal-title":"Indian J Med Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41684-024-01476-2","article-title":"Toward a common interpretation of the 3Rs principles in animal research","volume":"53","author":"Lauwereyns","year":"2024","journal-title":"Lab Anim"},{"key":"B25","first-page":"667","article-title":"Replacement, reduction and refinement: ethical considerations in the current applications of the 3Rs","author":"Tadich","year":"2023"},{"key":"B26","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1017\/S0007114517002227","article-title":"The 3Rs in research: a contemporary approach to replacement, reduction and refinement","volume":"120","author":"MacArthur Clark","year":"2018","journal-title":"Br J Nutr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/S00580-019-02910-5","article-title":"The effects of different doses of onion (Allium cepa. L) extract on leptin, ghrelin, total antioxidant capacity, and performance of suckling lambs","volume":"28","author":"Amiri","year":"2019","journal-title":"Comp Clin Path"},{"key":"B28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.22159\/AJPCR.2017.V10I3.16271","article-title":"Evaluation for nephroprotective activity of ethanolic extract of Allium cepa linn. in gentamicin-induced nephrotoxicity in rats","volume":"10","author":"Chinnala","year":"2017","journal-title":"Asian J Pharm Clin Res"},{"key":"B29","author":"Tripathi","year":""},{"key":"B30","author":"Dhanaraj Bhandare","year":""},{"key":"B31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1182\/HEMATOLOGY.2021000260","article-title":"Immunology 101: fundamental immunology for the practicing hematologist","volume":"2021","author":"Carty","year":"2021","journal-title":"Hematology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.3390\/CANCERS13164090","article-title":"The impact of induction regimes on immune responses in patients with multiple myeloma","volume":"13","author":"Firer","year":"2021","journal-title":"Cancers"},{"key":"B33","doi-asserted-by":"publisher","first-page":"17583","DOI":"10.3390\/IJMS242417583","article-title":"How neutrophils shape the immune response: reassessing their multifaceted role in health and disease","volume":"24","author":"Shafqat","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"6340","DOI":"10.3390\/IJMS24076340","article-title":"Neutrophils in health and disease: from receptor sensing to inflammasome activation","volume":"24","author":"Iwaniuk","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1146\/ANNUREV-BIOENG-112315-031200","article-title":"The lymphatic system in disease processes and cancer progression","volume":"18","author":"Padera","year":"2016","journal-title":"Annu Rev Biomed Eng"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.3390\/IJMS22094458","article-title":"In sickness and in health: the immunological roles of the lymphatic system","volume":"22","author":"Johnson","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"170","DOI":"10.31254\/PHYTO.2025.14307","article-title":"Extraction, isolation, and antimicrobial evaluation of bioactive compounds from the ethanolic extract of Allium cepa L","volume":"14","author":"Aboagye","year":"2025","journal-title":"J Phytopharmacol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3390\/BIOLOGY14081088","article-title":"Exploring the therapeutic potential of Allium cepa and Allium sativum extracts: current strategies, emerging applications, and sustainability utilization","volume":"14","author":"Bedir","year":"2025","journal-title":"Biology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"E170","DOI":"10.1073\/PNAS.1210419110\/-\/DCSUPPLEMENTAL","article-title":"Defining principles of combination drug mechanisms of action","volume":"110","author":"Pritchard","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B40","author":"Morgan","year":""},{"key":"B41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.35629\/7781-0705437443","article-title":"Immunomodulatory study of some herbal medicinal plants: a review","volume":"7","author":"Mishra","year":"2022","journal-title":"Int J Pharm Res Appl"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.23880\/VIJ-16000167","article-title":"A review on immunomodulatory effects of plant extracts","volume":"2","author":"Bhat","year":"2018","journal-title":"Virol Immunol J"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1632416","DOI":"10.3389\/FIMMU.2025.1632416\/TEXT","article-title":"Editorial: innate immune dysregulation: a driving force of autoimmunity and chronic inflammation","volume":"16","author":"Akbarzadeh","year":"2025","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1146\/ANNUREV-IMMUNOL-083122-043545","article-title":"Innate immunity in protection and pathogenesis during coronavirus infections and COVID-19","volume":"42","author":"Subbarao Malireddi","year":"2024","journal-title":"Annu Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/S40104-022-00796-Y","article-title":"The dual antimicrobial and immunomodulatory roles of host defense peptides and their applications in animal production","volume":"13","author":"Wu","year":"2022","journal-title":"J Anim Sci Biotechnol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1505571","DOI":"10.3389\/FMICB.2024.1505571\/FULL","article-title":"Immunomodulatory peptides: new therapeutic horizons for emerging and re-emerging infectious diseases","volume":"15","author":"Chatterjee","year":"2024","journal-title":"Front Microbiol"}],"container-title":["Frontiers in Tuberculosis"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftubr.2026.1874315\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:24:36Z","timestamp":1785990276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftubr.2026.1874315\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":46,"alternative-id":["10.3389\/ftubr.2026.1874315"],"URL":"https:\/\/doi.org\/10.3389\/ftubr.2026.1874315","relation":{},"ISSN":["2813-7868"],"issn-type":[{"value":"2813-7868","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"article-number":"1874315"}}